Alpha 2.0
Login Register
» Articles » PMID: 589316

Defective Blood Glucose Counter-regulation in Diabetics is a Selective Form of Autonomic Neuropathy

Overview
Journal Br Med J
Specialty General Medicine
Date 1977 Dec 10
PMID 589316
Citations 15
Authors
L V Campbell
E W Kraegen
L Lazarus
Affiliations
Soon will be listed here.
Abstract

Administration of a low-dose insulin infusion to normal subjects results in a mild drop in blood glucose concentration (1.1 mmol/1 (20 mg/100 ml)) and the resetting of the basal glucose at the lower concentration. Clinical hypoglycaemia does not develop, and there is a significant release of glucagon, growth hormone, and cortisol. A similar infusion in insulin-requiring diabetics results in hypoglycaemia accompanied by a release of growth hormone and cortisol but no significant release of glucagon. Subsequently giving arginine to these patients results in a significant release of glucagon, indicating that the alpha cell is intact and can respond to local, direct stimulation. In one patient the defect in glucagon response to impending hypoglycaemia developed after two years' insulin treatment. This type of dissociated response' of the alpha cell has been reported in animals after denervation of the pancreas, and insulin-requiring diabetics may develop a selective form of autonomic neuropathy affecting the vagal control of glucagon release.

Citing Articles

Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells.

Hamilton A, Zhang Q, Gao R, Hill T, Salehi A, Knudsen J Diabetes. 2024; 74(1):53-64.

PMID: 39475504 PMC: 11663815. DOI: 10.2337/db23-0809.

Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion.

Zhao Y, Zhou Y, Xiao M, Huang Y, Qi M, Kong Z J Diabetes. 2022; 14(5):334-344.

PMID: 35437937 PMC: 9366580. DOI: 10.1111/1753-0407.13268.

Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.

Bolli G, Calabrese G, De Feo P, Compagnucci P, Zega G, Angeletti G Diabetologia. 1982; 22(2):100-5.

PMID: 7037510 DOI: 10.1007/BF00254837.

Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes.

Santiago J, White N Ann Biomed Eng. 1980; 8(4-6):525-38.

PMID: 6794390 DOI: 10.1007/BF02363451.

Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Lager I, von Schenck H, Smith U Diabetologia. 1984; 26(5):337-42.

PMID: 6376242 DOI: 10.1007/BF00266033.

References
1.
ESTERHUIZEN A, SPRIGGS T, LEVER J . Nature of islet-cell innervation in the cat pancreas. Diabetes. 1968; 17(1):33-6. DOI: 10.2337/diab.17.1.33. View
2.
Gundersen H, Neubauer B . A long-term diabetic autonomic nervous abnormality. Reduced variations in resting heart rate measured by a simple and sensitive method. Diabetologia. 1977; 13(2):137-40. DOI: 10.1007/BF00745141. View
3.
Maher T, Tanenberg R, GREENBERG B, Hoffman J, DOE R, Goetz F . Lack of glucagon response to hypoglycemia in diabetic autonomic neuropathy. Diabetes. 1977; 26(3):196-200. DOI: 10.2337/diab.26.3.196. View
4.
Bloom S, Vaughan N, Russell R . Vagal control of glucagon release in man. Lancet. 1974; 2(7880):546-9. DOI: 10.1016/s0140-6736(74)91875-3. View
5.
Walter R, Dudl R, Palmer J, ENSINCK J . The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest. 1974; 54(5):1214-20. PMC: 301668. DOI: 10.1172/JCI107864. View